Solanezumab is a monoclonal antibody being studied as a potential therapy for Alzheimer’s disease. The secondary analysis of the trials data demonstrated slowing of cognitive decline in the
Trastuzumab emtansine uses ImmunoGen’s TAP technology with the trastuzumab antibody and is in global development by Roche under an agreement between ImmunoGen and Genentech, a member of the
The study, which will enroll 44 children from the US, Chile and Mexico, aims to decrease luteinizing hormone (LH) to prepubertal levels at month 6 (Day 169) in
Three month, multi-site, double blind, randomized, placebo-controlled, parallel-group trial is designed to assess the safety, tolerability and potential effect of anatabine in subjects with Alzheimer’s disease. Previous tissue
Re-Load Male Enhancement is designed for men who want to improve their performance, while Re-Load 7 Hour Energy, made up of herbs, vitamins and energy producing D-Ribose, has
The company’s antiviral drugs are designed to target the function of capsid, a viral protein required for the replication and transmission of the virus particle. The important aspects
Based on an ongoing assessment of patients in a Phase II study that the company voluntarily suspended on 1 August 2012, the decision was taken and the FDA
Lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses. In
eHealth Saskatchewan is involved in coordinating, operating and maintaining other selected information technology systems in the province of Saskatchewan, Canada. Under the three-year contract, SAIC Canada will provide
FV-100 is an orally available nucleoside analogue, at present being developed for the treatment of shingles, a painful skin rash caused by reactivation of the varicella zoster virus,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.